blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1999129

EP1999129 - COMPOUNDS AND METHODS FOR INHIBITING HEPATITIS C VIRAL REPLICATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.11.2011
Database last updated on 22.05.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU
published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Intermune, Inc.
3280 Bayshore Boulevard
Brisbane, CA 94005 / US
[2011/03]
Former [2008/50]For all designated states
Intermune, Inc.
3280 Bayshore Boulevard
Brisbane, CA 94005 / US
For all designated states
Array Biopharma, Inc.
3200 Walnut Street
Boulder, CO 80301 / US
Inventor(s)01 / BEIGELMAN, Leonid
991 E. Grant Pl.
San Mateo, CA 94402 / US
02 / SEIWERT, Scott D.
828 Rockaway Beach Ave.
Pacifica, CA 94044 / US
03 / BLATT, Lawrence M.
10 Shoreview
San Francisco, CA 94121 / US
04 / ANDREWS, Steven
2020 Kentmore
Longmont, CO 80501 / US
05 / HAAS, Julia
2775 Lee Hill Drive
Boulder, CO 80302 / US
 [2008/50]
Representative(s)Paemen, Liesbet R.J., et al
De Clercq & Partners cvba Edgard Gevaertdreef 10 a
9830 Sint-Martens-Latem / BE
[2010/52]
Former [2008/50]Paemen, Liesbet R.J., et al
De Clercq, Brants & Partners E. Gevaertdreef 10 A
9830 Sint-Martens-Latem / BE
Application number, filing date06816857.410.10.2006
[2008/50]
WO2006US40049
Priority number, dateUS20050725564P11.10.2005         Original published format: US 725564 P
[2008/50]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007044893
Date:19.04.2007
Language:EN
[2007/16]
Type: A2 Application without search report 
No.:EP1999129
Date:10.12.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 19.04.2007 takes the place of the publication of the European patent application.
[2008/50]
Type: B1 Patent specification 
No.:EP1999129
Date:29.12.2010
Language:EN
[2010/52]
Search report(s)International search report - published on:EP02.10.2008
ClassificationIPC:C07D471/04
[2008/50]
CPC:
C07D487/04 (EP,US); C07D403/08 (KR); A61P31/12 (EP);
A61P31/14 (EP); A61P43/00 (EP); C07D207/08 (KR);
C07D471/04 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/50]
Extension statesAL05.05.2008
BA05.05.2008
HR05.05.2008
MK05.05.2008
RS05.05.2008
TitleGerman:VERBINDUNGEN UND VERFAHREN ZUR INHIBIERUNG DER REPLIKATION DES HEPATITIS-C-VIRUS[2008/50]
English:COMPOUNDS AND METHODS FOR INHIBITING HEPATITIS C VIRAL REPLICATION[2008/50]
French:COMPOSÉS ET MÉTHODES POUR L'INHIBITION DE LA RÉPLICATION DU VIRUS DE L'HÉPATITE C[2008/50]
Entry into regional phase05.05.2008National basic fee paid 
05.05.2008Designation fee(s) paid 
05.05.2008Examination fee paid 
Examination procedure05.05.2008Examination requested  [2008/50]
10.12.2008Amendment by applicant (claims and/or description)
25.03.2009Despatch of a communication from the examining division (Time limit: M04)
17.07.2009Reply to a communication from the examining division
14.08.2009Despatch of a communication from the examining division (Time limit: M04)
11.12.2009Reply to a communication from the examining division
02.02.2010Despatch of a communication from the examining division (Time limit: M04)
27.05.2010Reply to a communication from the examining division
21.07.2010Communication of intention to grant the patent
19.11.2010Fee for grant paid
19.11.2010Fee for publishing/printing paid
Opposition(s)30.09.2011No opposition filed within time limit [2011/49]
Fees paidRenewal fee
14.10.2008Renewal fee patent year 03
13.10.2009Renewal fee patent year 04
12.10.2010Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT29.12.2010
BE29.12.2010
CY29.12.2010
CZ29.12.2010
EE29.12.2010
FI29.12.2010
HU29.12.2010
LT29.12.2010
LV29.12.2010
NL29.12.2010
PL29.12.2010
RO29.12.2010
SI29.12.2010
SK29.12.2010
TR29.12.2010
BG29.03.2011
GR30.03.2011
IS29.04.2011
PT29.04.2011
[2013/45]
Former [2013/44]AT29.12.2010
BE29.12.2010
CY29.12.2010
CZ29.12.2010
EE29.12.2010
FI29.12.2010
LT29.12.2010
LV29.12.2010
NL29.12.2010
PL29.12.2010
RO29.12.2010
SI29.12.2010
SK29.12.2010
TR29.12.2010
BG29.03.2011
GR30.03.2011
IS29.04.2011
PT29.04.2011
Former [2011/38]AT29.12.2010
BE29.12.2010
CY29.12.2010
CZ29.12.2010
EE29.12.2010
FI29.12.2010
LT29.12.2010
LV29.12.2010
NL29.12.2010
PL29.12.2010
RO29.12.2010
SI29.12.2010
SK29.12.2010
BG29.03.2011
GR30.03.2011
IS29.04.2011
PT29.04.2011
Former [2011/37]AT29.12.2010
BE29.12.2010
CY29.12.2010
CZ29.12.2010
EE29.12.2010
FI29.12.2010
LT29.12.2010
LV29.12.2010
PL29.12.2010
RO29.12.2010
SI29.12.2010
SK29.12.2010
BG29.03.2011
GR30.03.2011
IS29.04.2011
PT29.04.2011
Former [2011/36]AT29.12.2010
BE29.12.2010
CY29.12.2010
CZ29.12.2010
EE29.12.2010
FI29.12.2010
LT29.12.2010
LV29.12.2010
PL29.12.2010
SI29.12.2010
SK29.12.2010
BG29.03.2011
GR30.03.2011
IS29.04.2011
PT29.04.2011
Former [2011/35]AT29.12.2010
BE29.12.2010
CY29.12.2010
CZ29.12.2010
EE29.12.2010
FI29.12.2010
LT29.12.2010
LV29.12.2010
SI29.12.2010
BG29.03.2011
GR30.03.2011
IS29.04.2011
PT29.04.2011
Former [2011/33]AT29.12.2010
BE29.12.2010
CY29.12.2010
FI29.12.2010
LT29.12.2010
LV29.12.2010
SI29.12.2010
BG29.03.2011
Former [2011/30]AT29.12.2010
CY29.12.2010
FI29.12.2010
LT29.12.2010
LV29.12.2010
SI29.12.2010
BG29.03.2011
Former [2011/19]LT29.12.2010
Cited inInternational search[A]WO2004093915  (BOEHRINGER INGELHEIM INT [DE], et al) [A] 1-16* abstract *;
 [A]WO2005037214  (INTERMUNE INC [US], et al) [A] 1-26 * abstract *;
 [A]WO2005070955  (BOEHRINGER INGELHEIM INT [DE], et al) [A] 1-26 * abstract *
by applicantUS3547119
 US4211771
 US4311137
 US4531937
 US4755173
 EP0276120
 EP0294160
 US4806347
 US5082659
 US5190751
 CA1321348
 US5310562
 US5372808
 US5382657
 WO9533764
 WO9611953
 US5518729
 WO9621468
 WO9706804
 US5633388
 WO9743310
 US5711944
 US5716632
 WO9817679
 WO9822496
 US5824784
 WO9846597
 WO9846630
 US5866684
 US5869253
 WO9907733
 WO9907734
 US5908121
 WO9938888
 WO9950230
 US5980884
 US5985265
 US5985263
 WO9964442
 US6018020
 US6017328
 WO0009543
 WO0009558
 US6090822
 WO0059929
 WO0066623
 US6172046
 US6177074
 US6245740
 US6277830
 WO03064416
 WO03064455
 WO03064456
 US6608027
 US2004110795
    - METAVIR, HEPATOLOGY, (1994), vol. 20, pages 15 - 20
    - BRUNT, HEPATOL., (2000), vol. 31, pages 241 - 246
    - ALPINI, J. HEPATOL, (1997), vol. 27, pages 371 - 380
    - BARONI ET AL., HEPATOL., (1996), vol. 23, pages 1189 - 1199
    - CZAJA ET AL., HEPATOL., (1989), vol. 10, pages 795 - 800
    - GROSSMAN ET AL., J. GASTROENTEROL. HEPATOL., (1998), vol. 13, pages 1058 - 1060
    - ROCKEY; CHUNG, J. INVEST. MED., (1994), vol. 42, pages 660 - 670
    - SAKAIDA ET AL., J. HEPATOL., (1998), vol. 28, pages 471 - 479
    - SHI ET AL., PROC. NATL. ACAD. SCI. USA, (1997), vol. 94, pages 10663 - 10668
    - BARONI ET AL., LIVER, (1999), vol. 19, pages 212 - 219
    - LORTAT-JACOB ET AL., J. HEPATOL., (1997), vol. 26, pages 894 - 903
    - LLORENT ET AL., J. HEPATOL., (1996), vol. 24, pages 555 - 563
    - BALISH ET AL., J. INFECT. DISEASES, (1992), vol. 166, pages 1401 - 1403
    - KATAYAMA ET AL., J. VIRAL HEPATITIS, (2001), vol. 8, pages 180 - 185
    - WANDL; 1992 ET AL., BR. J. HAEMATOL., vol. 81, pages 516 - 519
    - WANDL ET AL., SEM. ONCOL., (1992), vol. 19, pages 88 - 94
    - BALISH ET AL., J. INFECTIOUS DISEASES, (1992), vol. 166, pages 1401 - 1403
    - DIJK ET AL., INT. J. CANCER, (1994), vol. 56, pages 262 - 268
    - SUNDMACHER ET AL., CURRENT EYE RES., (1987), vol. 6, pages 273 - 276
    - TORRE ET AL., J. MED. VIROL., (2001), vol. 64, pages 455 - 459
    - BEKKERING ET AL., J. HEPATOL., (2001), vol. 34, pages 435 - 440
    - ZEUZEM ET AL., GASTROENTEROL., (2001), vol. 120, pages 1438 - 1447
    - ZEUZEM, J. HEPATOL., (1999), vol. 31, pages 61 - 64
    - KEEFFE; HOLLINGER, HEPATOL., (1997), vol. 26, pages 101S - 107S
    - WILLS, CLIN. PHARMACOKINET., (1990), vol. 19, pages 390 - 399
    - HEATHCOTE ET AL., NEW ENGL. J. MED., (2000), vol. 343, pages 1673 - 1680
    - HUSA; HUSOVA, BRATISL. LEK. LISTY, (2001), vol. 102, pages 248 - 252
    - GLUE ET AL., CLIN. PHARMACOL., (2000), vol. 68, pages 556 - 567
    - BAILON ET AL., BIOCONJ. CHEM., (2001), vol. 12, pages 195 - 202
    - NEUMANN ET AL., SCIENCE, (2001), vol. 282, page 103
    - ZALIPSKY, ADV. DRUG DELIVERY REVIEWS S, (1995), vol. 16, pages 157 - 182
    - MANN ET AL., LANCET, (2001), vol. 358, pages 958 - 965
    - ZEUZEM ET AL., NEW ENGL. J. MED., (2000), vol. 343, pages 1666 - 1672
    - OSBORN; 2002 ET AL., J. PHARMACOL. EXP. THERAP., vol. 303, pages 540 - 548
    - SHEPPARD ET AL., NAT. IMMUNOL., (2003), vol. 4, pages 63 - 68
    - CHANG ET AL., NAT. BIOTECHNOL., (1999), vol. 17, pages 793 - 797
    - ADOLF, MULTIPLE SCLEROSIS, (1995), vol. 1, no. 1, pages 544 - 547
    - CHU ET AL., TET. LETT., (1996), pages 7229 - 7232
    - ANTIVIRAL RESEARCH, (1996), vol. 30, no. 1, page A23
    - STEINKUHLER ET AL., BIOCHEM., vol. 37, pages 8899 - 8905
    - INGALLINELLA ET AL., BIOCHEM., vol. 37, pages 8906 - 8914
    - KNODELL, HEPATOL., (1981), vol. 1, page 431
    - SCHEUER, J. HEPATOL., (1991), vol. 13, page 372
    - ISHAK, J. HEPATOL., (1995), vol. 22, pages 696 - 699
 US20050093884
 US20050702195
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.